Search research articles
Contact Us
Filters
Showing results (101-110 of 107) with videos related to
Page
of 11
Sort By:
You have reached the last page of results.
This site can display upto 107 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 28, 2022
Impact of RNA Signatures on pCR and Survival after 12-Week Neoadjuvant Pertuzumab plus Trastuzumab with or without Paclitaxel in the WSG-ADAPT HER2+/HR- Trial
Monika Graeser, Oleg Gluz, Claudia Biehl, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 22, 2023
De-Escalated Neoadjuvant Trastuzumab-Emtansine With or Without Endocrine Therapy Versus Trastuzumab With Endocrine Therapy in HR+/HER2+ Early Breast Cancer: 5-Year Survival in the WSG-ADAPT-TP Trial
Nadia Harbeck, Ulrike A Nitz, Matthias Christgen, et al.
The Lancet. Oncology
|
May 3, 2025
Chemotherapy-free neoadjuvant pembrolizumab combined with trastuzumab and pertuzumab in HER2-enriched early breast cancer (WSG-KEYRICHED-1): a single-arm, phase 2 trial
Sherko Kuemmel, Monika Graeser, Peter Schmid, et al.
Breast Cancer Research : BCR
|
February 14, 2025
HER2-low status as a distinct breast cancer subtype: myth or truth? Analysis of the WSG trials WSG-ADAPT-HR+/HER2-, WSG-PlanB, and WSG-ADAPT-TN
Gilda Schmidt, Oleg Gluz, Matthias Christgen, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
August 3, 2022
Results of a worldwide survey on the currently used histopathological diagnostic criteria for invasive lobular breast cancer
Maxim De Schepper, Anne Vincent-Salomon, Matthias Christgen, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
July 2, 2016
Standardized evaluation of tumor-infiltrating lymphocytes in breast cancer: results of the ring studies of the international immuno-oncology biomarker working group
Carsten Denkert, Stephan Wienert, Audrey Poterie, et al.
The Journal of Pathology. Clinical Research
|
December 10, 2021
Inter-observer agreement for the histological diagnosis of invasive lobular breast carcinoma
Matthias Christgen, Leonie Donata Kandt, Wiebke Antonopoulos, et al.
Page
of 11
Search research articles
Search
Showing results (101-110 of 107) with videos related to
Sort By:
Page
of 11
You have reached the last page of results.
This site can display upto 107 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 28, 2022
Impact of RNA Signatures on pCR and Survival after 12-Week Neoadjuvant Pertuzumab plus Trastuzumab with or without Paclitaxel in the WSG-ADAPT HER2+/HR- Trial
Monika Graeser, Oleg Gluz, Claudia Biehl, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 22, 2023
De-Escalated Neoadjuvant Trastuzumab-Emtansine With or Without Endocrine Therapy Versus Trastuzumab With Endocrine Therapy in HR+/HER2+ Early Breast Cancer: 5-Year Survival in the WSG-ADAPT-TP Trial
Nadia Harbeck, Ulrike A Nitz, Matthias Christgen, et al.
The Lancet. Oncology
|
May 3, 2025
Chemotherapy-free neoadjuvant pembrolizumab combined with trastuzumab and pertuzumab in HER2-enriched early breast cancer (WSG-KEYRICHED-1): a single-arm, phase 2 trial
Sherko Kuemmel, Monika Graeser, Peter Schmid, et al.
Breast Cancer Research : BCR
|
February 14, 2025
HER2-low status as a distinct breast cancer subtype: myth or truth? Analysis of the WSG trials WSG-ADAPT-HR+/HER2-, WSG-PlanB, and WSG-ADAPT-TN
Gilda Schmidt, Oleg Gluz, Matthias Christgen, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
August 3, 2022
Results of a worldwide survey on the currently used histopathological diagnostic criteria for invasive lobular breast cancer
Maxim De Schepper, Anne Vincent-Salomon, Matthias Christgen, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
July 2, 2016
Standardized evaluation of tumor-infiltrating lymphocytes in breast cancer: results of the ring studies of the international immuno-oncology biomarker working group
Carsten Denkert, Stephan Wienert, Audrey Poterie, et al.
The Journal of Pathology. Clinical Research
|
December 10, 2021
Inter-observer agreement for the histological diagnosis of invasive lobular breast carcinoma
Matthias Christgen, Leonie Donata Kandt, Wiebke Antonopoulos, et al.
Page
of 11